Your browser doesn't support javascript.
loading
The economic impact of the transition from branded to generic oncology drugs.
Cheung, W Y; Kornelsen, E A; Mittmann, N; Leighl, N B; Cheung, M; Chan, K K; Bradbury, P A; Ng, R C H; Chen, B E; Ding, K; Pater, J L; Tu, D; Hay, A E.
Afiliación
  • Cheung WY; University of Calgary, Calgary, AB.
  • Kornelsen EA; University of Calgary, Calgary, AB.
  • Mittmann N; University of Toronto, Toronto, ON.
  • Leighl NB; University of Toronto, Toronto, ON.
  • Cheung M; University of Toronto, Toronto, ON.
  • Chan KK; University of Toronto, Toronto, ON.
  • Bradbury PA; University of Toronto, Toronto, ON.
  • Ng RCH; University of Toronto, Toronto, ON.
  • Chen BE; Queen's University, Kingston, ON.
  • Ding K; Queen's University, Kingston, ON.
  • Pater JL; Queen's University, Kingston, ON.
  • Tu D; Queen's University, Kingston, ON.
  • Hay AE; Queen's University, Kingston, ON.
Curr Oncol ; 26(2): 89-93, 2019 04.
Article en En | MEDLINE | ID: mdl-31043808

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicamentos Genéricos / Neoplasias Pulmonares / Linfoma / Antineoplásicos Tipo de estudio: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Curr Oncol Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicamentos Genéricos / Neoplasias Pulmonares / Linfoma / Antineoplásicos Tipo de estudio: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Curr Oncol Año: 2019 Tipo del documento: Article
...